Detalhe da pesquisa
1.
Tumor endothelial ELTD1 as a predictive marker for treatment of renal cancer patients with sunitinib.
BMC Cancer
; 20(1): 339, 2020 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-32321460
2.
A systematic search strategy identifies cubilin as independent prognostic marker for renal cell carcinoma.
BMC Cancer
; 17(1): 9, 2017 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28052770
3.
Tumoral Pyruvate Kinase L/R as a Predictive Marker for the Treatment of Renal Cancer Patients with Sunitinib and Sorafenib.
J Cancer
; 10(14): 3224-3231, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31289593
4.
Tumoral cubilin is a predictive marker for treatment of renal cancer patients with sunitinib and sorafenib.
J Cancer Res Clin Oncol
; 143(6): 961-970, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28260162
5.
Tumoral ANXA1 Is a Predictive Marker for Sunitinib Treatment of Renal Cancer Patients.
J Cancer
; 8(19): 3975-3983, 2017.
Artigo
em Inglês
| MEDLINE | ID: mdl-29187872